Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,649 | -5,734 | -4,260 | -2,223 | -1,594 |
| Depreciation Amortization | -53 | 15 | 4 | 2 | 5 |
| Accounts receivable | -43 | -700 | -27 | -42 | -1 |
| Other Working Capital | 387 | -636 | -44 | -919 | -225 |
| Other Operating Activity | 1,256 | 1,359 | 427 | 159 | 252 |
| Operating Cash Flow | $-9,102 | $-5,696 | $-3,900 | $-3,023 | $-1,563 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,919 | N/A | N/A | N/A | N/A |
| PPE Investments | 11 | -50 | -22 | -7 | -3 |
| Investing Cash Flow | $-3,908 | $-50 | $-22 | $-7 | $-3 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 75 | 21,216 | 3,539 | 4,593 | 1,505 |
| Financing Cash Flow | $70 | $21,216 | $3,539 | $4,593 | $1,505 |
| Exchange Rate Effect | N/A | N/A | N/A | 8 | 24 |
| Beginning Cash Position | 16,823 | 1,353 | 1,736 | 166 | 204 |
| End Cash Position | 3,883 | 16,823 | 1,353 | 1,736 | 166 |
| Net Cash Flow | $-12,940 | $15,470 | $-383 | $1,570 | $-38 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,102 | -5,696 | -3,900 | -3,023 | -1,563 |
| Capital Expenditure | -2 | -50 | -22 | -7 | -3 |
| Free Cash Flow | -9,104 | -5,746 | -3,922 | -3,030 | -1,567 |